Colonization of adrenal glands and ovaries of mice by HSV-2 variants. I. Virological studies
- PMID: 2156486
- DOI: 10.1007/BF01311286
Colonization of adrenal glands and ovaries of mice by HSV-2 variants. I. Virological studies
Abstract
HSV-2 strain ER was shown to consist of variants with different pathogenic phenotype: Variant ER+ replicates to high titers in the adrenal glands and the ovaries but much less in the spleen; the testes were not colonized. ER+ migrates to the spinal ganglia and is highly neuroinvasive after i.p. inoculation. Variant ER- replicates 100-1,000 fold less in the adrenal glands and the ovaries, but proceeds to the spinal ganglia without invading the CNS. However, both variants are highly neuropathogenic after direct i.c. injection. We conclude that neuropathogenicity, neuroinvasiveness and the ability to replicate in the adrenal glands as well as ovaries are each determined by different sets of genes. Replication in mouse embryo fibroblasts--but not in Vero and adreno cortical carcinoma Y1 cells--is different for both strains. Also the adsorption capacity to cultured cells differs as shown by addition of D.S. 500. ER- is eliminated from the blood stream more quickly than ER+. Finally, C. parvum reduces the rate of replication of both variants in the adrenal and the ovaries. It is concluded that different adsorption and replications rates of variants ER+ and ER- in cell types critical for spread of HSV are responsible for the different pathobiological properties.
Similar articles
-
Colonization of adrenal glands and ovaries of mice by variants of HSV 1 and 2. II. Histopathological, immunohistochemical and in situ hybridization studies.Arch Virol. 1991;117(3-4):237-49. doi: 10.1007/BF01310768. Arch Virol. 1991. PMID: 2018430
-
Importance of the HpaI-P sequence for herpes simplex virus-1 replication in the adrenal glands.Arch Virol. 1990;113(3-4):151-63. doi: 10.1007/BF01316669. Arch Virol. 1990. PMID: 2171454
-
Herpes simplex virus type 1 and 2 in the adrenal glands: replication and histopathology.Arch Virol. 1986;90(3-4):207-22. doi: 10.1007/BF01317371. Arch Virol. 1986. PMID: 3015081
-
Asymptomatic vaginal herpes simplex virus infections in mice: virology and pathohistology.Arch Virol. 1996;141(2):263-74. doi: 10.1007/BF01718398. Arch Virol. 1996. PMID: 8634019
-
The RL neurovirulence locus in herpes simplex virus type 2 strain HG52 plays no role in latency.J Gen Virol. 1991 Sep;72 ( Pt 9):2305-10. doi: 10.1099/0022-1317-72-9-2305. J Gen Virol. 1991. PMID: 1654382
Cited by
-
A vaccinia virus--herpes simplex virus (HSV) glycoprotein B1 recombinant or an HSV vaccine overcome the HSV type 2 induced humoral immunosuppression and protect against vaginal challenge in BALB/c mice.Med Microbiol Immunol. 1994 May;183(2):87-94. doi: 10.1007/BF00277159. Med Microbiol Immunol. 1994. PMID: 7935163
-
Enhancement by TNF-alpha of reactivation and replication of latent herpes simplex virus from trigeminal ganglia of mice.Arch Virol. 1995;140(6):987-92. doi: 10.1007/BF01315409. Arch Virol. 1995. PMID: 7611887
-
Colonization of adrenal glands and ovaries of mice by variants of HSV 1 and 2. II. Histopathological, immunohistochemical and in situ hybridization studies.Arch Virol. 1991;117(3-4):237-49. doi: 10.1007/BF01310768. Arch Virol. 1991. PMID: 2018430
-
Pathogenesis of HSV-1/2 induced vaginitis/vulvitis of the mouse: dependence of lesions on genetic properties of the virus and analysis of pathohistology.Arch Virol. 1993;129(1-4):35-51. doi: 10.1007/BF01316883. Arch Virol. 1993. PMID: 8470958
-
Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement.Arch Virol. 1992;127(1-4):291-303. doi: 10.1007/BF01309591. Arch Virol. 1992. PMID: 1333754
References
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials